Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Connectivity Biomarkers in ADHD
NCT03709940Completed
- Sponsor
- King's College London
- Start
- May 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by King's College London. Primary endpoint: Diffusion imaging-based measurements as predictors of treatment response. Started May 2013; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT03709940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03709940.